Naive CD8+ T cell recruitment and proliferation are dependent on stage of dendritic cell maturation

European Journal of Immunology

Volumn 33, Issue 1, 2003, Pages 162-171

  Kaiser, Andrew ^a   Bercovici, Nadège ^a   Abastado, Jean Pierre ^a   Nardin, Alessandra ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Cancer; Cellular proliferation; CTL; Cytokine; Dendritic cell

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; TUMOR ANTIGEN;

ANTIGEN SPECIFICITY; CELL ACTIVATION; CELL COUNT; CELL KINETICS; CELL MATURATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; REVIEW; STEM CELL; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINES; DENDRITIC CELLS; INTERFERON TYPE II; NEOPLASM PROTEINS; TIME FACTORS;

EID: 0037258397     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/immu.200390019     Document Type: Review

References (29)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Vieira, P. L., de Jong, E. C., Wierenga, E. A., Kapsenberg, M. L. and Kalinski, P., Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 2000. 164: 4507-4512.
3. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F., Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000. 1: 311-316.
4. Kalinski, P., Schuitemaker, J. H., Hilkens, C. M., Wierenga, E. A. and Kapsenberg, M. L., Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 1999. 162: 3231-3236.
5. + T-helper and a T-killer cell. Nature 1998. 393: 474-478.
6. (+) cytotoxic T lymphocytes. J. Exp. Med. 2000. 191: 541-550.
7. Buller, R. M., Holmes, K. L., Hugin, A., Frederickson, T. N. and Morse, H. C., 3rd, Induction of cytotoxic T cell responses in vivo in the absence of CD4 helper cells. Nature 1987. 328: 77-79.
8. + T cells: CD4-independent help. J. Immunol. 2001. 167: 1283-1289.
9. Mintern, J. D., Davey, G. M., Belz, G. T., Carbone, F. R. and Heath, W. R., Cutting edge: precursor frequency affects the helper dependence of cytotoxic T cells. J. Immunol. 2002. 168: 977-980.
10. Boccaccio, C., Jacod, S., Kaiser, A., Boyer, A., Abastado, J. P. and Nardin, A., Identification of a clinical-grade maturation factor for dendritic cells. J. Immunother. 2002. 25: 88-96.
11. Coulie, P. G., Brichard, V., Van Pel, A., at al., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1994. 180: 35-42.
12. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E. and Rosenberg, S. A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 1994. 180: 347-352.
13. (+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 1999. 190: 705-715.
14. Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K., Valmori, D., Liénard, D., Plum, J., MacDonald, H. R., Speiser, D. E., Cerottihi, J. C. and Romero, P., Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J. Exp. Med. 2002. 195: 485-494.
15. (+) T cells. J. Exp. Med. 2001. 194: 1711-1719.
16. Givan, A. L., Fisher, J. L., Waugh, M., Ernstoff, M. S. and Wallace, P. K., A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J. Immunol. Methods 1999. 230: 99-112.
17. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
18. + T lymphocytes. J. Immunol. 2001. 167: 181-187.
19. + T cells. J. Immunol. 2000. 165: 1182-1190.
20. Jonuleit, H., Giesecke-Tuettenberg, A., Tuting, T., Thurner-Schuler, B., Stuge, T. B., Paragnik, L., Kandemir, A., Lee, P. P., Schuler, G., Knop, J. and Enk, A. H., A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T cell responses in humans following intranodal injection. Int. J. Cancer 2001. 93: 243-251.
21. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. and Bhardwaj, N., Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001. 193: 233-238.
22. Lapointe, R., Toso, J. F., Butts, C., Young, H. A. and Hwu, P., Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur. J. Immunol. 2000. 30: 3291-3298.
23. + T lymphocyte responses in vitro using dendritic cells. J. Immunol. 1999. 162: 5197-5204.
24. Reis e Sousa, C., Yap, G., Schulz, O., Rogers, N., Schito, M., Aliberti, J., Hieny, S. and Sher, A., Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 1999. 11: 637-647.
25. (+) CTL in vivo. J. Immunol. 2001. 167: 5027-5033.
26. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnilk, A., Lebecque, S. and Caux, C., Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998. 188: 373-386.
27. + T cells in the development of T helper type 1 responses. J. Exp. Med. 2002. 195: 473-483.
28. Valmori, D., Fonteneau, J. F., Lizana, C. M., Gervols, N., Lienard, D., Rimoldi, D., Jongeneel, V., Jotereau, F., Cerottini, J. C. and Romero, P., Enhanced generation of specific tumorreactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 1998. 160: 1750-1758.
29. Goxe, B., Latour, N., Chokri, M., Abastado, J. P. and Salcedo, M., Simplified method to generate large quantities of dendritic cells suitable for clinical applications. Immunol. Invest. 2000. 29: 319-336.